about
The Epigenome as a therapeutic target for Parkinson's disease.Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development.BMP-Smad 1/5/8 signalling in the development of the nervous system.Roles for the TGFβ superfamily in the development and survival of midbrain dopaminergic neurons.Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease.Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation.Zeb2: A multifunctional regulator of nervous system development.Endocytosis contributes to BMP2-induced Smad signalling and neuronal growth.Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysis.A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons.Ventral midbrain neural stem cells have delayed neurogenic potential in vitro.Romidepsin induces caspase-dependent cell death in human neuroblastoma cells.Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease.Exposure to Hypertensive Disorders of Pregnancy Increases the Risk of Autism Spectrum Disorder in Affected Offspring.Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult.Canonical BMP-Smad signalling promotes neurite growth in rat midbrain dopaminergic neurons.Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations4-Hydroxychalcone Induces Cell Death via Oxidative Stress in MYCN-Amplified Human Neuroblastoma CellsProtocol for evaluation of neurotrophic strategies in Parkinson's disease-related dopaminergic and sympathetic neurons in vitro
P50
Q37548331-9980E966-EC4A-4684-942C-67E048D36F10Q38100525-0B28BBC4-DE65-4E99-BFE9-F6D8B66B1C74Q38124634-51D83EA5-2B5D-4D8B-8351-F7078F80F2FDQ38185993-2A132FA4-E15A-4E13-90CE-072B190A45DDQ38271199-D5A2FCC5-2844-45DA-882C-B9CC4452F9C5Q38368133-942BFC8E-DE5E-481D-8883-2BFB78B8B5AFQ38550847-E92CFE3A-FA27-4989-A245-5B4A2346702FQ38716841-826FBD39-DBC5-4737-BAAB-DC1D2A1E2E29Q38755597-54542437-04D8-47DF-B577-2C566FB24BF1Q38766912-802342BA-9B0E-4BFD-883D-EDB722BB93BCQ39129524-C2CC2248-592E-42CC-BBD6-966E7CC9F06FQ45831785-F5699508-5915-481B-8300-1C2CC59DBD4FQ46365515-56036847-736F-43DA-99DB-CCA4D335EFC7Q47098541-B06B9634-DC43-4A97-9B92-1B52D4D1217DQ47750469-068A1D89-AF97-4053-A409-06B9898D6B61Q48635091-4FCE4E9E-5CD4-49AA-BF46-D8E8CDFF054FQ50674031-D78A36F6-DA63-4293-9857-A37E5CD68C7FQ90393911-4AAF04A8-4DAD-4E88-A8C4-E953AC82DEF1Q92309382-4E33ACB5-B09E-49F1-BF89-2166F3E82205Q92893059-91415196-D228-4B95-9FF9-5846D702E318
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shane V Hegarty
@ast
Shane V Hegarty
@en
Shane V Hegarty
@es
Shane V Hegarty
@nl
type
label
Shane V Hegarty
@ast
Shane V Hegarty
@en
Shane V Hegarty
@es
Shane V Hegarty
@nl
altLabel
Shane V. Hegarty
@en
prefLabel
Shane V Hegarty
@ast
Shane V Hegarty
@en
Shane V Hegarty
@es
Shane V Hegarty
@nl
P1053
P-1001-2016
P106
P1153
55674818800
P2798
P31
P496
0000-0003-3456-0770